Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL13 Variant (Active) Protein

This protein is expressed in Escherichia coli (E. coli).
Catalog No. ABIN988038

Quick Overview for IL13 Variant (Active) Protein (ABIN988038)

Target

IL13 Variant

Biological Activity

Active

Origin

Human

Source

  • 1
Escherichia coli (E. coli)

Purity

> 95 % by SDS-PAGE and HPLC analyses.
  • Sequence

    SPGPVPPSTA LRELIEELVN ITQNQKAPLC NGSMVWSINL TAGMYCAALE SLINVSGCSA IEKTQRMLSG FCPHKVSAGQ FSSLHVRDTK IEVAQFVKDL LLHLKKLFRE GQF

    Characteristics

    Fully biologically active when compared to standard. The ED50 as determined by the dose-dependent proliferation of TF-1 cells was < 1.0 ng/ml, corresponding to a specific activity of > 1×106 units/mg. This analog has also been shown to exhibit increased in vivo activity compared to wild type IL-13.

    Endotoxin Level

    Level Less than 1EU/µg of rHuIL-13 variant as determined by LAL method
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at < -20 °C. Further dilutions should be made in appropriate buffered solutions.

    Storage

    4 °C
  • Target

    IL13 Variant

    Alternative Name

    Interleukin-13 Variant (IL-13 V)

    Background

    The human IL-13 cDNA encodes a 132 amino acid protein containing a proposed 20 amino acid signal peptide. Human IL-13 shares approximately 30% amino acid sequence homology to human IL-4 and the two cytokines exhibit overlapping biological activities. Human IL-13 is produced by activated Th0, Th1-like Th2-like and CD8 T cells. Similarly to IL-4, IL-13 has multiple effects on the differentiation and functions of monocytes/macrophages. IL-13 can suppress the cytotoxic functions of monocytes/macrophages. It can also suppress the production of proinflammatory cytokines and upregulate the production of IL-1ra by monocytes/macrophages. Synonym: Interleukin-13 Variant ( IL-13 V), Human. Formulation: Lyophilized from a 0.2µm filtered concentrated solution in PBS, pH 7.2, containing 5% trehalose.

    Molecular Weight

    Approximately 12.5 kDa, a single non-glycosylated polypeptide chain containing 114 amino acids, with a substitution of Q for R at position 112 compared with the wild type IL-13.
You are here:
Chat with us!